Thursday - May 22, 2025
VCU-led Research Highlights Semaglutide's Potential for Treating Fatty Liver Disease
May 02, 2025
RICHMOND, Virginia, May 2 -- Virginia Commonwealth University issued the following news:

* * *

VCU-led research highlights semaglutide's potential for treating fatty liver disease

International study suggests that the substance in Ozempic and Wegovy can reverse liver damage in patients.

By A.J. Hostetler, Stravitz-Sanyal Institute for Liver Disease and Metabolic Health

An international study led by the director of Virginia Com . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products